Top Bispecific Antibody Companies in United Arab Emirates

Biologix plays a crucial role in bringing innovative drugs to the MENA region, with a focus on rare disease management.

Hayat Biotech is focused on delivering innovative biotechnological solutions, including monoclonal antibodies, which are relevant to the development of bispecific antibodies. Their commitment to advancing life sciences positions them as a key player in this area.

Biotech Pharma specializes in the pharmaceutical sector, focusing on areas such as Hematology and Oncology. With over a decade of experience, they are committed to providing high-quality medications and services to healthcare providers in the Middle East.

NewBridge Pharmaceuticals is a specialty company focused on partnering with global pharma and biotech firms to commercialize innovative therapeutics in the MENA region. Their commitment to addressing unmet medical needs may include bispecific antibodies among their portfolio of U.S. FDA or EMA approved products.

Genpharm is a prominent pharmaceutical market access company that focuses on niche therapeutics for rare diseases and specialty care. They provide tailored market access solutions and have established exclusive partnerships with leading global pharmaceutical companies, enhancing the availability of innovative treatments in the MENAT region.

The company, SciBioGen, is a prominent provider of laboratory products and services across the Gulf Region and East Africa, catering to various markets including pharmaceuticals. With a commitment to innovative solutions and a strong support team, they ensure access to high-quality scientific equipment and reagents.

Actina is a leader in life science innovation, developing innovative concepts and cutting-edge technologies that could be relevant for partners interested in advanced therapies like bispecific antibodies. Their focus on providing agile solutions and long-term success aligns with the needs of the life science industry.

Integrated Gulf Biosystems (IGB) is dedicated to advancing Life Sciences through innovative solutions in Basic Research and Molecular Diagnostics, which is crucial for translational research and may include developments relevant to bispecific antibodies. Their extensive portfolio and commitment to customer partnerships position them as a key player in the Life Science and Clinical Genomic Solutions landscape in the Middle East.

Triangle Medical Trading is a prominent pharmaceutical trading company in the UAE, specializing in the import, distribution, and marketing of high-quality pharmaceuticals and dietary supplements. Their commitment to staying updated with the latest science and building strong relationships with key accounts positions them as a trusted source for healthcare professionals.

The company highlights its expertise in hyaluronic acid for ophthalmology and rheumatology, which may relate to the development of bispecific antibodies through innovative therapeutic approaches. Their commitment to healthcare and proactive compliance with regulations underscores their focus on advancing medical solutions.